Patent · US Active

PH20 polypeptide variants, formulations and uses thereof

US12152262B2 · kind B2 · utility

0Cited by
89References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 23, 2023
Grant dateNov 26, 2024
Priority date—
Expiry dateJun 23, 2043

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.